Clinical Trial Update: Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial investigating irradiated donor cells after stem cell transplant to control cancer in patients with hematologic malignancies; the study is term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia in Remission
• Hematopoietic Cell Transplantation Recipient Disease

Drugs mentioned

• irradiated donor cells following stem cell transplant

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia in Remission | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2023-06-26